299
Views
29
CrossRef citations to date
0
Altmetric
Review

The use of hypomethylating agents in the treatment of hematologic malignancies

& , M.D., Ph.D.
Pages 1676-1695 | Received 16 Mar 2007, Accepted 01 Jun 2007, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Hazem E. Hassan, Jean-Arnaud Keita, Lawrence Narayan, Sean M. Brady, Richard Frederick, Samuel Carlson, Karen C. Glass, Senthil Natesan, Thomm Buttolph & Tamer E. Fandy. (2016) The combination of dimethoxycurcumin with DNA methylation inhibitor enhances gene re-expression of promoter-methylated genes and antagonizes their cytotoxic effect. Epigenetics 11:10, pages 740-749.
Read now
Jacqueline S Garcia, Nitin Jain & Lucy A Godley. (2010) An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes. OncoTargets and Therapy 3, pages 1-13.
Read now

Articles from other publishers (27)

Nassiba Taib, Maysaloun Merhi, Varghese Inchakalody, Sarra Mestiri, Shereena Hydrose, Karama Makni-Maalej, Afsheen Raza, Fairooz Sahir, Fouad Azizi, Parveen B. Nizamuddin, Queenie Fernandes, Zeenath Safira K. M. Yoosuf, Salam Almoghrabi, Lobna Al-Zaidan, Alaaeldin Shablak, Shahab Uddin, Cristina Maccalli, Mohammed Ussama Al Homsi & Said Dermime. (2023) Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy. Journal of Translational Medicine 21:1.
Crossref
Yuan Yuan Shi, Long Su, Zeng Yan Liu, Yi Geng Cao, Xin Chen, Rong Li Zhang, Qing Zhen Liu, Jian Feng Yao, Wei Hua Zhai, Qiao Ling Ma, Er Lie Jiang & Ming Zhe Han. (2023) A 7-Day Decitabine-Included Conditioning Regimen Accelerated Donor Hematopoietic Engraftment while Reduced the Occurrence of Mucositis without Interfering with Prognosis. Chemotherapy 68:3, pages 143-154.
Crossref
Aysun Adan. 2023.
Utku Iltar, Fadime Nurcan Alhan, Ece Vural, Ünal Ataş, Hasan Sözel, Ömer Doğan, Ahmet Boduroğlu, Orhan Kemal Yücel, Ozan Salim & Levent Ündar. (2021) Recurrent arthritis as an unexpected side effect associated with azacitidine in a patient with myelodysplastic syndrome. Journal of Oncology Pharmacy Practice, pages 107815522110497.
Crossref
Wen Shen, Chao Gao, Ramon Cueto, Lu Liu, Hangfei Fu, Ying Shao, William Y. Yang, Pu Fang, Eric T. Choi, Qinghua Wu, Xiaofeng Yang & Hong Wang. (2020) Homocysteine-methionine cycle is a metabolic sensor system controlling methylation-regulated pathological signaling. Redox Biology 28, pages 101322.
Crossref
Ordoñez, Martínez-Calle, Agirre & Prosper. (2019) DNA Methylation of Enhancer Elements in Myeloid Neoplasms: Think Outside the Promoters?. Cancers 11:10, pages 1424.
Crossref
Shuang Zhao, Ye Zhang, Xujun Liang, Maoyu Li, Fang Peng, Zhuchu Chen & Yongheng Chen. (2019) Detection and Analysis of RNAs Expression Profile for Methylated Candidate Tumor Suppressor Genes in Nasopharyngeal Carcinoma. Anti-Cancer Agents in Medicinal Chemistry 19:6, pages 772-782.
Crossref
MIKA HOSOKAWA, MAI SAITO, AIKO NAKANO, SAKURA IWASHITA, AYANO ISHIZAKA, KUMIKO UEDA & SEIGO IWAKAWA. (2015) Acquired resistance to decitabine and cross-resistance to gemcitabine during the long-term treatment of human HCT116 colorectal cancer cells with decitabine. Oncology Letters 10:2, pages 761-767.
Crossref
Nicola Amodio, Marco Rossi, Lavinia Raimondi, Maria Rita Pitari, Cirino Botta, Pierosandro Tagliaferri & Pierfrancesco Tassone. (2015) miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies. Oncotarget 6:15, pages 12837-12861.
Crossref
Kirstin Lund, John J Cole, Nathan D VanderKraats, Tony McBryan, Nikolay A Pchelintsev, William Clark, Mhairi Copland, John R Edwards & Peter D Adams. (2014) DNMT inhibitors reverse a specific signature of aberrant promoter DNA methylation and associated gene silencing in AML. Genome Biology 15:7.
Crossref
Erika L. Moen, Amy L. Stark, Wei Zhang, M. Eileen Dolan & Lucy A. Godley. (2014) The Role of Gene Body Cytosine Modifications in MGMT Expression and Sensitivity to Temozolomide . Molecular Cancer Therapeutics 13:5, pages 1334-1344.
Crossref
Leandro Cerchietti & John P. Leonard. (2013) Targeting the epigenome and other new strategies in diffuse large B-cell lymphoma: beyond R-CHOP. Hematology 2013:1, pages 591-595.
Crossref
Thomas Clozel, ShaoNing Yang, Rebecca L. Elstrom, Wayne Tam, Peter Martin, Matthias Kormaksson, Samprit Banerjee, Aparna Vasanthakumar, Biljana Culjkovic, David W. Scott, Sarah Wyman, Micheal Leser, Rita Shaknovich, Amy Chadburn, Fabrizio Tabbo, Lucy A. Godley, Randy D. Gascoyne, Katherine L. Borden, Giorgio Inghirami, John P. Leonard, Ari Melnick & Leandro Cerchietti. (2013) Mechanism-Based Epigenetic Chemosensitization Therapy of Diffuse Large B-Cell Lymphoma. Cancer Discovery 3:9, pages 1002-1019.
Crossref
Relja Popovic, Mrinal Y. Shah & Jonathan D. Licht. (2012) Epigenetic therapy of hematological malignancies: where are we now?. Therapeutic Advances in Hematology 4:2, pages 81-91.
Crossref
Ho Kang. (2012) Decitabine, a DNA methyltransferase inhibitor, induces apoptosis in human leukemia cells through intracellular reactive oxygen species generation. International Journal of Oncology.
Crossref
Stefanie Kewitz, Toralf Bernig & Martin S. Staege. (2012) Histone deacetylase inhibition restores cisplatin sensitivity of Hodgkin's lymphoma cells. Leukemia Research 36:6, pages 773-778.
Crossref
Abid Hamid. (2012) Folate Malabsorption and its Influence on DNA Methylation During Cancer Development. DNA and Cell Biology, pages 120402085903000.
Crossref
Ioannis S. Vizirianakis, Maria Chatzopoulou, Ioannis D. Bonovolias, Ioannis Nicolaou, Vassilis J. Demopoulos & Asterios S. Tsiftsoglou. (2010) Toward the Development of Innovative Bifunctional Agents To Induce Differentiation and To Promote Apoptosis in Leukemia: Clinical Candidates and Perspectives. Journal of Medicinal Chemistry 53:19, pages 6779-6810.
Crossref
Xiang Zhang, Mengchu Wu, Hong Xiao, Ming‐Tsung Lee, Linda Levin, Yuet‐Kin Leung & Shuk‐Mei Ho. (2010) Methylation of a single intronic CpG mediates expression silencing of the PMP24 gene in prostate cancer . The Prostate 70:7, pages 765-776.
Crossref
Alison M. Michie, Alison M. McCaig, Rinako Nakagawa & Milica Vukovic. (2009) Death‐associated protein kinase (DAPK) and signal transduction: regulation in cancer. The FEBS Journal 277:1, pages 74-80.
Crossref
J. A. Watson, C. J. Watson, A.-M. McCrohan, K. Woodfine, M. Tosetto, J. McDaid, E. Gallagher, D. Betts, J. Baugh, J. O'Sullivan, A. Murrell, R. W. G. Watson & A. McCann. (2009) Generation of an epigenetic signature by chronic hypoxia in prostate cells. Human Molecular Genetics 18:19, pages 3594-3604.
Crossref
Adriana C. Drost, Sibylle Weng, Gerhard Feil, Jochen Schäfer, Simon Baumann, Lothar Kanz, Karl-Dietrich Sievert, Arnulf Stenzl & Robert Möhle. (2009) In vitro Myogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells as a Potential Treatment for Urethral Sphincter Muscle Repair. Annals of the New York Academy of Sciences 1176:1, pages 135-143.
Crossref
Eric Solary, Vincent Ribrag & Stéphane de Botton. 2009. ABC Transporters and Multidrug Resistance. ABC Transporters and Multidrug Resistance 315 347 .
Ruth Plummer, Laura Vidal, Melanie Griffin, Mark Lesley, Johann de Bono, Sally Coulthard, Julieann Sludden, Lillian L. Siu, Eric X. Chen, Amit M. Oza, Gregory K. Reid, A. Robert McLeod, Jeffrey M. Besterman, Chooi Lee, Ian Judson, Hilary Calvert & Alan V. Boddy. (2009) Phase I Study of MG98, an Oligonucleotide Antisense Inhibitor of Human DNA Methyltransferase 1, Given as a 7-Day Infusion in Patients with Advanced Solid Tumors. Clinical Cancer Research 15:9, pages 3177-3183.
Crossref
M. L. Orta, S. Mateos & F. Cortes. (2009) DNA demethylation protects from cleavable complex stabilization and DNA strand breakage induced by the topoisomerase type I inhibitor camptothecin. Mutagenesis 24:3, pages 237-244.
Crossref
K el-Shami & B D Smith. (2008) Immunotherapy for myeloid leukemias: current status and future directions. Leukemia 22:9, pages 1658-1664.
Crossref
Khaldoun Al-Romaih, Bekim Sadikovic, Maisa Yoshimoto, Yuzhuo Wang, Maria Zielenska & Jeremy A. Squire. (2008) Decitabine-Induced Demethylation of 5′ CpG Island in GADD45A Leads to Apoptosis in Osteosarcoma Cells. Neoplasia 10:5, pages 471-480.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.